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I mage-guided needle biopsy is widely used for the diagnosis of lesions in various organs [1-5].  Although 
the diagnostic yield is generally high,  the biopsy is 
occasionally non-diagnostic due to insufficient speci-
mens.  Hence,  there is a continued need for needle 
biopsy techniques that can yield larger specimens.  
Recently,  a new type of semi-automatic cutting biopsy 
needle (STARCUT aspiration type; TSK Laboratory,  
Tochigi,  Japan) was introduced,  which consists of a 
lumen to apply negative pressure by manual aspiration 
while cutting the tissue.  An ex-vivo study showed that 
the application of negative pressure contributed to an 
increase in the amount of specimen obtained [6].  To 
date,  however,  there have been no data on the efficacy 
of this needle in humans.  The purpose of this clinical 
study was to evaluate the efficacy of this needle in a clin-
ical setting by comparing the weight of the specimens 
obtained with and without aspiration in percutaneous 
lung and renal biopsy procedures.
Materials and Methods
Study design and population. This was a single- 
center prospective clinical study conducted with the 
approval of our institutional review board (rin1706-
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An aspiration-type semi-automatic cutting biopsy needle enables tissue cutting during application of negative 
pressure,  which is expected to contribute to a larger amount of specimen.  The aim of the present study was to 
evaluate this novel needle in a clinical setting.  Patients who underwent image-guided percutaneous biopsy for 
lung or renal masses were enrolled.  Cutting biopsy was performed with and without aspiration during each 
procedure.  The specimens were weighed using an electronic scale.  The weights were compared between speci-
mens obtained with and without aspiration using a paired t-test.  The data from 45 lung and 30 renal biopsy 
procedures were analyzed.  In lung biopsy,  the mean ± standard deviation weights of specimens obtained with 
and without aspiration were 2.20 ± 1.05 mg and 2.24 ± 1.08 mg,  respectively.  In renal biopsy,  the mean weights 
were 6.52 ± 2.18 mg and 6.42 ± 1.62 mg,  respectively.  The weights were not significantly different between spec-
imens obtained with and without aspiration either in lung (p= 0.799) or renal (p= 0.789) biopsies.  The applica-
tion of negative pressure with the aspiration-type semi-automatic cutting biopsy needle did not contribute to an 
increase in the amount of the specimen obtained in lung and renal biopsies.
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004).  The study protocol was registered in the 
University Hospital Medical Information Network 
Clinical Trials Registry (UMIN000027427).  The pri-
mary endpoint was the weight (mg) of the specimens 
obtained using the aspiration-type semiautomatic nee-
dle in a percutaneous lung and a renal biopsy procedure 
group.  The hypothesis was that the mean weight of 
specimens obtained with aspiration would be signifi-
cantly greater than that of the specimens obtained with-
out aspiration.  The sample size was calculated to 
achieve a power of 80% for the paired t-test at a signifi-
cance level of 0.05 under the assumption that the differ-
ence between the weight of the specimens obtained with 
and without aspiration is 1.18 mg (standard deviation 
[SD]: 0.6),  referring to the previously published ex- 
vivo study [6].  Based on this calculation,  the target 
sample size was set as 30 subjects for renal biopsy.  It was 
set as 45 subjects for lung biopsy because the lung spec-
imens were expected to be lighter and thus a larger tar-
get sample size was considered necessary.
Patients who met the eligibility criteria (Table 1) 
between July 2017 and January 2018 were included.  In 
the present study,  the weight of specimens obtained by 
biopsy with and without aspiration was compared in 
each patient.  In such a comparison,  there is a risk of 
bias due to the difference in the specimen weight 
between the first and second firing.  To address this bias,  
the participants were randomly allocated to the follow-
ing two cohorts using a random number table generated 
by a computer program (R,  version 3.2.5): cohort A,  
in which the first firing was done with aspiration and 
the second without,  and cohort B,  in which the first 
firing was done without and the second with aspiration 
(Fig. 1).
Biopsy procedure. Percutaneous biopsy proce-
dures were performed using an aspiration-type semiau-
tomatic cutting biopsy needle (Fig. 2A , B) by an experi-
enced radiologist,  or a radiology trainee under the 
direct supervision of an experienced radiologist.  
Computed tomography (CT) fluoroscopy-guidance was 
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Fig. 1　 A schema of patient allocation.
Table 1　 Eligibility critera
Inclusion criteria
1. Image-guided biopsy for a lung or renal lesion indicated in the patient.
2. Long axis diameter of the target lesion ≥1.0 cm.
3. Age of the patient 20 years or older.
4. Written informed consent provided by the patient.
Exclusion criteria
1. Lung lesion with ground-glass opacity on high-resolution computed tomography.
2. Lung or renal lesion with necrotic portion.
3.  Laboratory findings of white blood-cell count ＜2,000/µL,  hemoglobin ＜6.0 g/dL,  platelet count ＜50,000/µL,  or prothrombin time- 
international normalized ratio ＞1.5.
4. Pregnant Status.
5. Mental disorders including dementia.
6. Inability to keep rest during the biopsy procedure.
7. Inappropriateness of the candidate for the study judged by the investigators because of other reasons.
used in the lung biopsy,  and either CT fluoroscopy- or 
ultrasound (US)-guidance was used in the renal biopsy.  
Under local anesthesia,  an 18G or 20G biopsy needle 
was inserted through an 17G or 19G introducer needle 
(i.e.,  the coaxial method) or directly without an intro-
ducer needle,  and was advanced to the proximal edge of 
the target lesion.  Following this,  the inner stylet of the 
biopsy needle was advanced 11 mm or 22 mm into the 
lesion.  After inspecting the position of the inner stylet 
on the image,  the tissue was cut by firing the cannula.  
The method of firing with aspiration was as follows: i) 
A 20-ml syringe (SS-20LZ; Terumo,  Tokyo) and a 
50-cm extension tube with a three-way stopcock (RX1-
FL50; TOP,  Tokyo) were connected to the hub of the 
biopsy needle; ii) negative pressure was applied by 
pulling the plunger back to the 20-ml mark; and iii) the 
stopcock was closed to maintain the negative pressure 
during firing (Fig. 2A , B).  The specimen was scraped 
from the needle using filter paper.  After measuring the 
weight,  the specimen was submitted for histopatholog-
ical analysis.  After completion of the biopsy,  CT or US 
scanning was performed to evaluate adverse events 
(AEs).  For lung biopsy,  a chest radiograph was also 
taken 3 hours after the procedure and again the follow-
ing morning.
Measurement of specimen weight. An electronic 
scale with a readability of 0.01 mg (AUW120D semi- 
micro balance; Shimadzu,  Kyoto,  Japan) was used to 
measure the weight of the specimen.  The method used 
was as follows: i) the weight of the filter paper was 
measured before biopsy (weight A); ii) the weight of the 
specimen was measured with the filter paper used for 
scraping it (weight B); and iii) the specimen weight 
(mg) was calculated by subtracting “weight A” from 
“weight B”.
Data collection and statistical analysis. Data on 
the characteristics of patients,  lesions,  procedures,  and 
postprocedural AEs were summarized by descriptive 
statistics.  All the AEs were graded according to 
Common Terminology Criteria for Adverse Events 
(CTCAE) version 4.0 <http: //evs.nci.nih.gov/ftp1/
CTCAE/About.html> (accessed September,  2013).  
Using data from both cohort A and B,  the weight of the 
specimens obtained with aspiration was compared with 
that of the specimens obtained without aspiration by a 
paired t-test.  Statistical analysis was performed using 
SPSS version 22.0 (IBM,  Armonk,  NY,  USA).  A p 
value of less than 0.05 was considered significant.
Results
The patient flow chart is shown in Fig. 3.  In total,  47 
and 31 patients were registered for lung and renal 
biopsy,  respectively.  Two lung biopsy procedures were 
cancelled because of withdrawal of consent or shrinkage 
of the lesion.  One renal biopsy procedure was excluded 
from the analysis due to deviation from protocol.  Thus,  
the data from 45 lung and 30 renal biopsy procedures 
were submitted for the analysis.  The characteristics of 
patients,  lesions,  and procedures,  as well as postproce-
dural AE rates are summarized in Table 2.
In lung biopsy,  the mean weights ± SD of specimens 
obtained with and without aspiration were 
2.20±1.05 mg (range: 0.21-4.08 mg) and 2.24 ±1.08 mg 
(range: 0.12-3.87 mg),  respectively.  In renal biopsy,  
they were 6.52 ± 2.18 mg (range: 1.63-9.52 mg) and 
6.42 ± 1.62 mg (range: 2.58-8.85 mg),  respectively.  No 
significant difference in weight was observed between 
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A B
Fig. 2　 An aspiration-type semiautomatic cutting biopsy needle.  Negative pressure is applied while cutting the tissue by manual aspira-
tion using a syringe (A; arrow) and an extension tube connected to the hub (A; arrowhead) of the biopsy needle,  through the lumen in the 
inner stylet (B; asterisks).
the specimens obtained with and without aspiration 
either in lung (p = 0.799) or renal (p = 0.789) biopsy 
(Fig. 4A , B).
The pathological result was diagnostic in 45 cases 
(100%) and 29 cases (96.7%) of lung and renal biopsy,  
respectively (Table 3).  In one non-diagnostic renal 
biopsy,  the report suggested the specimen was obtained 
from normal kidney parenchyma rather than the target.
Discussion
In needle biopsy procedures,  it is crucial to obtain a 
sufficient amount of the specimen in order to achieve 
diagnostic success.  The aspiration-type semi-automatic 
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Table 2　 Summary of patients,  lesions,  procedures,  and adverse events
Lung biopsy (n=45) Renal biopsy (n=30)
Age (mean±SD,  years) 68.6±11.4 57.4±15.9
Sex (male/female) 27/18 19/11
Lesion size (mean±SD,  mm) 19.2±9.4 28.3±14.4
Needle size (18G/20G) 0/45 29/1
Coaxial method (used/not used) 42/3 30/0
Adverse events＊(%)
　Pneumothorax,  grade 1 14 (31.1) -
　Pneumothorax,  grade 2 5 (11.1) -
　Pulmonary hemorrhage,  grade 1 3 (6.7) -
　Pulmonary hemorrhage,  grade 2 2 (4.4) -
　Hemothorax,  grade 1 2 (4.4)
　Thoracic wall hematoma,  grade 1 1 (2.2) -
　Retroperitoneal hemorrhage,  grade 1 - 16 (53.3)
　Retroperitoneal hemorrhage,  grade 2 - 1 (3.3)
　Vasovagal reflex,  grade 3 - 1 (3.3)
＊Adverse events were graded according to Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.
Fig. 3　 Patient flow chart.  Two lung biopsy procedures were cancelled because of withdrawal of consent or shrinkage of the lesion.  One 
renal biopsy procedure was excluded from the analysis because of deviation from protocol; specifically,  both the first and second firing 
were performed without aspiration.
cutting biopsy needle is designed to increase the 
amount of specimen by the application of negative pres-
sure during tissue cutting.  This needle was previously 
tested in ex-vivo bovine liver and collapsed lung models,  
with significantly heavier specimens obtained in the 
aspiration group in the liver model [6].  The present 
study was the first trial to investigate the efficacy of this 
needle in a clinical setting.
In the present study,  contrary to the hypothesis,  
there was no significant difference in specimen weight 
between the specimens obtained with and without aspi-
ration.  This discrepancy might be attributable to differ-
ences in methodology: the previous report used ex-vivo 
animal normal parenchyma while we used in-vivo 
human tumorous tissue.  Thus,  the different nature of 
the specimens might have affected the results.  Most of 
the specimens obtained in the present study were cancer 
tissues from lung and renal biopsies.  Cancer tissues are 
generally considered to be stiffer than normal organ 
tissues [7]; aspiration might not sufficiently pull such 
tissues into the needle tray.  In addition,  cancer tissues 
might be more heterogeneous than normal tissues.  The 
weight of the specimen obtained from such heteroge-
nous tissues is more likely to vary by a subtle change of 
needle position for each firing; therefore,  the differ-
ence of weight caused by aspiration might not be as 
significant as observed in homogeneous normal tissues.  
In addition,  specimens were acquired repeatedly from 
the same subject in the previous ex-vivo study,  and such 
repeated intra-subject measurements could have biased 
the results.
The types of adverse events observed after biopsy 
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Table 3　 Pathological diagnosis
Lung biopsy (n=45) Renal biopsy (n=30)
Diagnosis n (%) Diagnosis n (%)
Adenocarcinoma 22 (48.9) Clear cell RCC 20 (66.7)
Squamous cell carcinoma 4 (8.9) Chromophobe RCC 2 (6.7)
Non-small cell carcinoma 1 (2.2) Papillary RCC 2 (6.7)
Small cell carcinoma 1 (2.2) RCC,  unspecified 3 (10.0)
Metastatic tumor 4 (8.9) Oncocytoma 2 (6.7)
Lymphoma 2 (4.4) Non-diagnostic 1 (3.3)
Solitary fibrous tumor 1 (2.2)
Fungal disease 2 (4.4)
Granulomatous lesion 5 (11.1)
Fibrous tissue 3 (6.7)
RCC: renal cell carcinoma.
A B
p = 0.799＊ p = 0.789＊
Fig. 4　 Comparison between the weights of specimens obtained with and without aspiration in lung (A) and renal (B) biopsy using the 
paired t-test.
with the aspiration-type semi-automatic cutting biopsy 
needle did not differ from those commonly observed 
after percutaneous lung and renal biopsy.  There was no 
extraordinary adverse event specifically related to the 
aspiration technique.  Also,  the incidence of common 
adverse events (e.g.,  pneumothorax in lung biopsy and 
retroperitoneal hemorrhage in renal biopsy) was similar 
to that by conventional techniques [3 , 8].
As a limitation of this study,  the specimens obtained 
with and without aspiration were not separately evalu-
ated by the pathologist and thus the diagnostic outcome 
of each technique could not be directly compared.
In conclusion,  use of the aspiration-type semiauto-
matic cutting biopsy needle did not contribute to an 
increase in the amount of the specimen obtained in lung 
and renal biopsies.
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